| 06/03/24 | 07:00:08 | 6 Mar 2024 | | FY23 Preliminary Results |
| 01/03/24 | 14:00:01 | 1 Mar 2024 | | Issue of Equity and Total Voting Rights |
| 29/02/24 | 18:00:00 | 29 Feb 2024 | | Directorate Change |
| 13/02/24 | 16:00:00 | 13 Feb 2024 | | Share Incentive Plan - Director/PDMR Shareholding |
| 02/02/24 | 16:30:00 | 2 Feb 2024 | | Holding(s) in Company |
| 01/02/24 | 12:00:01 | 1 Feb 2024 | | Issue of Equity and Total Voting Rights |
| 22/01/24 | 07:00:10 | 22 Jan 2024 | | Expansion of leadership team |
| 11/01/24 | 17:30:00 | 11 Jan 2024 | | Share Incentive Plan - Director/PDMR Shareholding |
| 11/01/24 | 17:30:00 | 11 Jan 2024 | | Employee Stock Purchase Plan - PDMR Notification |
| 09/01/24 | 07:00:04 | 9 Jan 2024 | | FY23 trading update |
| 03/01/24 | 07:00:03 | 3 Jan 2024 | | Presentation at 42nd Annual J.P. Morgan Conference |
| 02/01/24 | 16:00:00 | 2 Jan 2024 | | Director/PDMR Shareholding (ESPP) |
| 02/01/24 | 16:00:00 | 2 Jan 2024 | | Issue of Equity and Total Voting Rights |
| 19/12/23 | 14:00:00 | 19 Dec 2023 | | Appointment of Two Non-Executive Directors |
| 12/12/23 | 17:00:00 | 12 Dec 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 07/12/23 | 16:30:00 | 7 Dec 2023 | | Nanopore Community Meeting Technology Update |
| 01/12/23 | 17:00:00 | 1 Dec 2023 | | Issue of Equity and Total Voting Rights |
| 30/11/23 | 07:00:14 | 30 Nov 2023 | | National Australian rare disease programme |
| 13/11/23 | 17:00:00 | 13 Nov 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 13/11/23 | 12:00:00 | 13 Nov 2023 | | Participation in upcoming investor conferences |
| 07/11/23 | 08:30:00 | 7 Nov 2023 | | Admission to Trading on the London Stock Exchange |
| 06/11/23 | 07:00:13 | 6 Nov 2023 | | Issue of Equity |
| 01/11/23 | 16:00:01 | 1 Nov 2023 | | Issue of Equity and Total Voting Rights |
| 31/10/23 | 07:00:15 | 31 Oct 2023 | | Apple showcases Oxford Nanopore in M3 launch |
| 26/10/23 | 18:10:00 | 26 Oct 2023 | | Holding(s) in Company |
| 24/10/23 | 12:30:00 | 24 Oct 2023 | | Holding(s) in Company |
| 23/10/23 | 08:30:00 | 23 Oct 2023 | | Issue of Equity and Total Voting Rights |
| 23/10/23 | 08:30:00 | 23 Oct 2023 | | Admission to Trading on the London Stock Exchange |
| 19/10/23 | 07:00:11 | 19 Oct 2023 | | Capital Markets Day - ONT expands into clinical |
| 19/10/23 | 07:00:11 | 19 Oct 2023 | | bioMérieux makes investment in Oxford Nanopore |
| 19/10/23 | 07:00:11 | 19 Oct 2023 | | Mayo Clinic and Oxford Nanopore collaboration |
| 11/10/23 | 15:30:01 | 11 Oct 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 06/10/23 | 15:00:01 | 6 Oct 2023 | | Block Listing Interim Review |
| 02/10/23 | 16:00:01 | 2 Oct 2023 | | Issue of Equity and Total Voting Rights |
| 27/09/23 | 17:00:02 | 27 Sept 2023 | | Director Declaration |
| 12/09/23 | 15:00:01 | 12 Sept 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 12/09/23 | 07:00:07 | 12 Sept 2023 | | Presentation at the Morgan Stanley Conference |
| 06/09/23 | 07:00:05 | 6 Sept 2023 | | Interim results for the 6 months ended 30 June 23 |
| 01/09/23 | 15:00:01 | 1 Sept 2023 | | Issue of Equity and Total Voting Rights |
| 25/08/23 | 12:00:01 | 25 Aug 2023 | | Notice of Results and Capital Markets Day |
| 11/08/23 | 17:00:01 | 11 Aug 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 01/08/23 | 17:30:01 | 1 Aug 2023 | | Issue of Equity and Total Voting Rights |
| 17/07/23 | 07:00:05 | 17 Jul 2023 | | Half Year Trading Update |
| 13/07/23 | 15:30:17 | 13 Jul 2023 | | Kate Priestman appointed as Non-Executive Director |
| 11/07/23 | 17:30:01 | 11 Jul 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 03/07/23 | 15:30:02 | 3 Jul 2023 | | Issue of Equity and Total Voting Rights |
| 13/06/23 | 16:00:01 | 13 Jun 2023 | | Share Incentive Plan - Director/PDMR Shareholding |
| 12/06/23 | 15:30:00 | 12 Jun 2023 | | Result of AGM |
| 12/06/23 | 07:00:05 | 12 Jun 2023 | | National German rare disease study |
| 09/06/23 | 07:00:06 | 9 Jun 2023 | | Change of Broker |
